Europe PMC
Nothing Special   »   [go: up one dir, main page]

Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Author Correction: High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial.

Show less

Author information

Affiliations

  • 1. Department of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
      Authors
    • van Dorp J 1, 3
    (1 author)
  • 2. Inivata Ltd., Babraham Research Park, Cambridge, UK.
      Authors
    • Pipinikas C 2
    • Marsico G 2
    • Hackinger S 2
    • Amarante T 2
    • McLay K 2
    • Rosenfeld N 2
    • Jones G 2
    (7 authors)
  • 3. Dutch Uro-Oncology Study Group, Bilthoven, The Netherlands.
      Authors
    • van Dorp J 1, 3
    • Suelmann BBM 3
    • Mehra N 3
    • van Dijk N 3
    • van Montfoort ML 3
    • van de Kamp MW 3
    • Hendricksen K 3
    • de Feijter JM 3
    • Boellaard TN 3
    • Meijer RP 3
    • van der Heijden AG 3
    • van Rhijn BWG 3
    • van der Heijden MS 3
    (13 authors)
  • 4. Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.
      Authors
    • Braaf LM 4
    (1 author)
  • 5. Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.
      Authors
    • van Steenis C 5
    (1 author)
    • Show all (7)

ORCIDs linked to this article

Nature Medicine, 01 Jan 2024, 30(1):304
https://doi.org/10.1038/s41591-023-02500-7 PMID: 37460757 

This corrects "High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial." Nat Med. 2023 Mar;29(3):588-592.

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1038/s41591-023-02500-7

Read article for free, from open access legal sources, via Unpaywall: https://www.nature.com/articles/s41591-023-02500-7.pdfUnpaywall

Citations & impact 

Impact metrics

1
Citation
Jump to Citations

Alternative metrics

Altmetric item for https://www.altmetric.com/details/151605270
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/151605270

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Funding 

Funders who supported this work.

Cancer Research UK (1)